secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Therapeutics, Inc. (ODTX)
CIK:        0001882782
Form:       8-K
Filed at:   2026-09-08T23:10:19+00:00
Accession:  0001193125-26-385477
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Therapeutics posts corporate presentation; no financial details in 8-K
------------------------------------------------------------------------------

- Odyssey Therapeutics posted a corporate presentation on its investor relations website on September 8, 2026.
- The 8-K filing only announces the posting; the presentation's content is not included in the filing.
- No financial results, guidance, or material business developments are disclosed in the filing.
- Investors should review the presentation on the company's IR page for any updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526385477/0001193125-26-385477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526385477/odtx-20260908.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-385477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer